Device Trial Radar · NCT03379272
Comparison Of NeuroNaute Smart System to a Standard EleCTroencephalogram System in Hospital
Last checked: Nov 19, 2026Latest source record: Nov 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Dec 20, 2020
Primary completion
Dec 20, 2020
Study completion Dec 20, 2020
Sponsor
- Lead sponsor
- BioSerenityNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Pitié-Salpêtrière Hospital
- First posted
- Dec 20, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The proposed study is designed to evaluate the performance of the Neuronaute in comparison with the gold standard EEG in patients with a regular appointment at the hospital. The design of this study is guided by two overriding factors : (i) epileptics disorders suspected or either (ii) epileptics already diagnosed. Volunteers will be asked to participate to this study. This study will enroll 35 outpatient subjects aged 18 to 85. Informed consent will be obtained from the patients, and assent from the subjects, prior to any form of assessment or intervention as part of the study. Patients will be submitted to the studied device record Neuronaute following by the gold standard EEG. A grid with all EEG activity recorded during the trial will be provided for evaluation after completion of the trial.
Conditions
- Epilepsy
Interventions
GOLDSTANDARDDevice
RECORDING WITH EEG GOLDSTANDARD
NEURONAUTEDevice
RECORDING WITH NEURONAUTE
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reproducibility of electroencephalographic signals interpretation recorded by the Neuronaute compared to the gold standard.Time frame: 1 year
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.